Table 2.

Multivariate model for the incidence of cGvHD

COX ModelHRP95% CI
Immunoprophylaxis
 CsA/MTX1.30.600.46–3.74
 TKR/MTX0.790.620.3–1.98
 TKR/RAPA1
Donor
 Related0.70.440.284–1.73
 Unrelated1
Vit D*FokI0.02
Among FokI = CC:
 Vit D versus control1.020.960.41–2.55
Among FokI = CT
 Vit D versus control0.140.0010.045–0.45
Among FokI = TT
 Vit D versus control0.20.0960.034–1.32
Among vit D = control:
 CT versus CC2.070.160.7–5.8
 TT versus CC1.750.430.4–7.2
Among vit D = vit D:
 CT versus CC0.30.020.1–0.8
 TT versus CC0.30.190.08–1.7
  • Abbreviations: CsA, cyclosporine A; MTX, methotrexate; RAPA, rapamycin; TKR, tacrolimus.